NeRRe Therapeutics announces positive findings from Phase 2b study with orvepitant in chronic cough

by NASDAQ Market News June 7, 2019

NASDAQ Market News
Click here to email author

Amarin to Present Findings Regarding Challenges of Current Treatment Options in Reducing Cardiovascular Risks for Diabetes Patients, Even for Those With Controlled Cholesterol Levels, at Annual American Diabetes Association (ADA) Meeting

Helsinn Group supports two events with the International Society for Cutaneous Lymphomas (ISCL) at the 24th World Congress of Dermatology

Ads